Pfizer Inc
LSE:0Q1N
Pfizer Inc
LSE:0Q1N
Price:
27.38
USD
-1.26%
Market Cap:
$250.4B
Relative Value
The Relative Value of one
0Q1N
stock under the Base Case scenario is
32.6
USD.
Compared to the current market price of 27.38 USD,
Pfizer Inc
is
Undervalued by 16%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
0Q1N
Relative Value
Base Case
32.6
USD
Undervaluation 16%
Multiples Across Competitors
0Q1N Competitors Multiples
Pfizer Inc Competitors
Pfizer Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Pfizer Inc
LSE:0Q1N
|
156.1B USD | 2.5 | 20.1 | 7.5 | 10 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
982.7B USD | 15.1 | 47.6 | 32.1 | 34.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
294.5B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
243B GBP | 5.7 | 32.5 | 17.9 | 25.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
247.9B CHF | 5.7 | 22.8 | 14 | 18 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.6B USD | 4.7 | 16.6 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.8B EUR | 2.8 | 16.1 | 8.1 | 11.5 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
92.6B GBP | 2.8 | 16.2 | 8.1 | 11.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
